TTN and neoplasm: Subsequently, our univariate analysis of TTN gene mutations and clinicopathological characteristics showed that survival status, pN stage, smoking history, and history of neoadjuvant treatment were associated with TTN mutations, while gender, age, pathological stage, new tumor event type, and radiation/chemotherapy were not associated with TTN mutations in LUSC (Table 1).